At Fluxion, we’re passionate about delivering cell-based and cell-free solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.
New plate format allows users to test bacterial growth on a variety of substrates
Alameda, CA, January 10, 2019 - Fluxion Biosciences, a leading developer of automated solutions for cellular analysis in life sciences research and drug discovery, today announced that it has launched a new BioFlux plate format that allows users to test custom substrates.
A promising approach to preventing bacterial colony formation on medical devices is the use of surfaces that are resistant to bacterial attachment and continuing with matrix growth. The proper in vitro modeling of such biofilms needs devices that can simulate the in vivo conditions in terms of shear forces, nutrient delivery, and substrate material. Previous studies have used coupons placed in macro-scale bioreactors to achieve substrate testing. This new custom BioFlux plate format allows researchers to test virtually any material, while preserving the BioFlux system advantages of high parallelism, shear force, low media consumption, and temperature/gas control.
The plates are made with a 3mm access port into the microfluidic channels, surrounded by a pressure sensitive adhesive surface. Any custom substrate can then be adhered to close the bottom of the chamber and create a leak-proof flow conduit. More information about the plates can be found on the consumables page.
The new custom substrate plate is available for use on all BioFlux systems.